CCMH
PFE icon

Cornerstone Capital Management Holdings’s Pfizer PFE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$78.2M Sell
2,275,957
-335,478
-13% -$11.4M 0.55% 27
2017
Q3 		$88.5M Buy
2,611,435
+309,128
+13% +$9.94M 0.69% 21
2017
Q2 		$73.4M Buy
2,302,307
+4,395
+0.2% +$139K 0.58% 24
2017
Q1 		$74.6M Sell
2,297,912
-199,288
-8% -$6.28M 0.58% 21
2016
Q4 		$77M Sell
2,497,200
-275,623
-10% -$8.41M 0.59% 23
2016
Q3 		$89.1M Buy
2,772,823
+77,782
+3% +$2.6M 0.66% 18
2016
Q2 		$90M Buy
2,695,041
+197,722
+8% +$6.31M 0.72% 15
2016
Q1 		$70.2M Sell
2,497,319
-296,393
-11% -$8.47M 0.59% 27
2015
Q4 		$85.6M Buy
2,793,712
+19,626
+0.7% +$617K 0.7% 19
2015
Q3 		$82.7M Buy
2,774,086
+67,382
+2% +$2.16M 0.77% 15
2015
Q2 		$86.1M Buy
2,706,704
+51,979
+2% +$1.69M 0.76% 12
2015
Q1 		$87.6M Sell
2,654,725
-30,384
-1% -$966K 0.82% 11
2014
Q4 		$79.4M Buy
2,685,109
+41,151
+2% +$1.18M 0.81% 15
2014
Q3 		$74.2M Sell
2,643,958
-60,589
-2% -$1.7M 0.8% 14
2014
Q2 		$76.2M Buy
2,704,547
+79,598
+3% +$2.27M 0.84% 12
2014
Q1 		$80M Sell
2,624,949
-137,672
-5% -$4.1M 0.93% 10
2013
Q4 		$80.3M Sell
2,762,621
-183,913
-6% -$5.35M 0.92% 10
2013
Q3 		$80.3M Sell
2,946,534
-213,589
-7% -$5.81M 0.96% 10
2013
Q2 		$84M Buy
+3,160,123
New +$87.3M 1.04% 12

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cornerstone Capital Management Holdings's PFE Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Pfizer (PFE) stake by 13% in Q4 2017, selling an estimated $11.4M and leaving 2,275,957 shares worth $78.2M. The position accounts for 0.55% of the portfolio, ranked #27.

Cornerstone Capital Management Holdings first reported a position in PFE in Q2 2013 and has held it in 19 quarters since. The position peaked at $90M in Q2 2016. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Cornerstone Capital Management Holdings held 2,275,957 shares of Pfizer worth $78.2M as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 335,478 Pfizer shares in Q4 2017, an estimated $11.4M.
  • Pfizer made up 0.55% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #27 holding.
  • Cornerstone Capital Management Holdings first reported a position in Pfizer in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's Pfizer position peaked at $90M in Q2 2016.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.